BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawanaka H, Akahoshi T, Kinjo N, Konishi K, Yoshida D, Anegawa G, Yamaguchi S, Uehara H, Hashimoto N, Tsutsumi N. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg. 2010;251:76-83. [PMID: 19864937 DOI: 10.1097/sla.0b013e3181bdf8ad] [Cited by in Crossref: 79] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Kim BR, Oh J, Yu KS, Ryu HG. Pharmacokinetics of human antithrombin III concentrate in the immediate postoperative period after liver transplantation. Br J Clin Pharmacol 2020;86:923-32. [PMID: 31840271 DOI: 10.1111/bcp.14200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Yoshida D, Nagao Y, Tomikawa M, Kawanaka H, Akahoshi T, Kinjo N, Uehara H, Hashimoto N, Hashizume M, Maehara Y. Predictive factors for platelet count after laparoscopic splenectomy in cirrhotic patients. Hepatol Int. 2011;Epub ahead of print. [PMID: 21959984 DOI: 10.1007/s12072-011-9315-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
3 Schultheiß M, Bettinger D, Thimme R. Nonsurgical Therapeutic Options in Portal Vein Thrombosis. Viszeralmedizin 2014;30:388-92. [PMID: 26288606 DOI: 10.1159/000369848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kim KS, Moon YJ, Kim SH, Kim B, Jun IG, Kwon HM, Song JG, Hwang GS. Low Preoperative Antithrombin III Level Is Associated with Postoperative Acute Kidney Injury after Liver Transplantation. J Pers Med 2021;11:716. [PMID: 34442360 DOI: 10.3390/jpm11080716] [Reference Citation Analysis]
5 Lai W, Lu SC, Li GY, Li CY, Wu JS, Guo QL, Wang ML, Li N. Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization. World J Gastroenterol 2012; 18(26): 3443-3450 [PMID: 22807615 DOI: 10.3748/wjg.v18.i26.3443] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
6 Kinjo N, Kawanaka H, Akahoshi T, Matsumoto Y, Kamori M, Nagao Y, Hashimoto N, Uehara H, Tomikawa M, Shirabe K, Maehara Y. Portal vein thrombosis in liver cirrhosis. World J Hepatol 2014; 6(2): 64-71 [PMID: 24575165 DOI: 10.4254/wjh.v6.i2.64] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
7 Qi X, Bai M, Guo X, Fan D. Pharmacologic prophylaxis of portal venous system thrombosis after splenectomy: a meta-analysis. Gastroenterol Res Pract 2014;2014:292689. [PMID: 25243008 DOI: 10.1155/2014/292689] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
8 Hashimoto N, Akahoshi T, Shoji T, Tomikawa M, Tsutsumi N, Yoshizumi T, Taketomi A, Shirabe K, Maehara Y. Successful treatment for hepatic encephalopathy aggravated by portal vein thrombosis with balloon-occluded retrograde transvenous obliteration. Case Rep Gastroenterol 2011;5:366-71. [PMID: 21769289 DOI: 10.1159/000330287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Zhang N, Yao Y, Xue W, Wu S. Early prophylactic anticoagulation for portal vein system thrombosis after splenectomy: A systematic review and meta-analysis. Biomed Rep 2016;5:483-90. [PMID: 27699018 DOI: 10.3892/br.2016.755] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
10 Xu M, Xue W, Ma Z, Bai J, Wu S. Resveratrol Reduces the Incidence of Portal Vein System Thrombosis after Splenectomy in a Rat Fibrosis Model. Oxid Med Cell Longev 2016;2016:7453849. [PMID: 27433290 DOI: 10.1155/2016/7453849] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
11 Wang M, Wei A, Zhang Z, Peng B. Laparoscopic Splenectomy for the Elderly Liver Cirrhotic Patients With Hypersplenism: A Retrospective Comparable Study. Medicine (Baltimore) 2016;95:e3012. [PMID: 26962816 DOI: 10.1097/MD.0000000000003012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
12 Harimoto N, Araki K, Muranushi R, Hoshino K, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Shibuya K, Miyazaki M, Kawanaka H, Shirabe K. Multimodal approach to portal hypertension and gastric varices before hepatic resection for hepatocellular carcinoma: a case report. Surg Case Rep 2020;6:190. [PMID: 32737609 DOI: 10.1186/s40792-020-00952-4] [Reference Citation Analysis]
13 Fujiyama S, Saitoh S, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Suzuki F, Arase Y, Ikeda K, Kumada H. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome. BMC Gastroenterol 2017;17:112. [PMID: 29070023 DOI: 10.1186/s12876-017-0668-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
14 Toyoda J, Morioka D, Horii N, Nakayama G, Oyama N, Asano F, Izumisawa Y, Miura M, Sato Y, Endo I. Treatment of acute exacerbation of liver-cirrhosis-associated portal vein thrombosis with direct-acting oral anticoagulant, edoxaban, used as an initial treatment in the early postoperative period after abdominal surgery: a case report. J Med Case Rep 2021;15:52. [PMID: 33563326 DOI: 10.1186/s13256-020-02651-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Cheng Z, Yu F, Tian J, Guo P, Li J, Chen J, Fan Y, Zheng S. A comparative study of two anti-coagulation plans on the prevention of PVST after laparoscopic splenectomy and esophagogastric devascularization. J Thromb Thrombolysis. 2015;40:294-301. [PMID: 25698403 DOI: 10.1007/s11239-015-1190-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
16 Zhou J, Wu Z, Pankaj P, Peng B. Long-term postoperative outcomes of hypersplenism: laparoscopic versus open splenectomy secondary to liver cirrhosis. Surg Endosc. 2012;26:3391-3400. [PMID: 22648114 DOI: 10.1007/s00464-012-2349-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
17 Suda T, Takatori H, Hayashi T, Horii R, Nio K, Terashima T, Iida N, Kitahara M, Shimakami T, Arai K, Yamashita T, Yamashita T, Mizukoshi E, Honda M, Okumura K, Kozaka K, Kaneko S. Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis. Life (Basel) 2020;10:E177. [PMID: 32899804 DOI: 10.3390/life10090177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Matsui T, Usui M, Wada H, Iizawa Y, Kato H, Tanemura A, Murata Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Isaji S. Platelet Activation Assessed by Glycoprotein VI/Platelet Ratio Is Associated With Portal Vein Thrombosis After Hepatectomy and Splenectomy in Patients With Liver Cirrhosis. Clin Appl Thromb Hemost. 2018;24:254-262. [PMID: 29050501 DOI: 10.1177/1076029617725600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Miyazawa K, Hara Y, Shimizu K, Nakanishi W, Tokodai K, Nakanishi C, Miyagi S, Kawagishi N, Ohuchi N. Hassab's operation for Joubert syndrome with congenital hepatic fibrosis: A case report. Int J Surg Case Rep 2017;34:134-8. [PMID: 28402911 DOI: 10.1016/j.ijscr.2017.03.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Tsutsumi N, Kawanaka H, Yamaguchi S, Sakai M, Momosaki S, Endo K, Ikejiri K. Huge inflammatory pseudotumor of the spleen with postoperative portal vein thrombosis: report of a case. Surg Today 2012;42:382-5. [PMID: 22160356 DOI: 10.1007/s00595-011-0081-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
21 Qi X, Han G, Ye C, Zhang Y, Dai J, Peng Y, Deng H, Li J, Hou F, Ning Z, Zhao J, Zhang X, Wang R, Guo X. Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients. Med Sci Monit. 2016;22:2528-2550. [PMID: 27432511 DOI: 10.12659/msm.898866] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 3.4] [Reference Citation Analysis]
22 Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H. Management of thrombocytopenia due to liver cirrhosis: A review. World J Gastroenterol 2014; 20(10): 2595-2605 [PMID: 24627595 DOI: 10.3748/wjg.v20.i10.2595] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
23 李陈婕, 羊志辉, 施小六, 卢放根, 刘德良. 肝硬化门静脉血栓形成危险因素的Meta分析. 世界华人消化杂志 2017; 25(3): 241-251 [DOI: 10.11569/wcjd.v25.i3.241] [Reference Citation Analysis]
24 Ghadimi K, Levy JH, Welsby IJ. Perioperative management of the bleeding patient. Br J Anaesth 2016;117:iii18-30. [PMID: 27940453 DOI: 10.1093/bja/aew358] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 19.7] [Reference Citation Analysis]
25 Cagin YF, Bilgic Y, Berber İ, Yildirim O, Erdogan MA, Firat F, Arslan AK, Colak C, Seckin Y, Harputluoglu M. The risk factors of portal vein thrombosis in patients with liver cirrhosis. Exp Ther Med 2019;17:3189-94. [PMID: 30936992 DOI: 10.3892/etm.2019.7300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
26 Uehara H, Kawanaka H, Nakanoko T, Sugiyama M, Ota M, Mano Y, Sugimachi K, Morita M, Toh Y. Successful hybrid surgery for ileal conduit stomal varices following oxaliplatin-based chemotherapy in a patient with advanced colorectal cancer. Surg Case Rep 2020;6:236. [PMID: 32990797 DOI: 10.1186/s40792-020-01021-6] [Reference Citation Analysis]
27 金山, 戴朝六. 脉高压症脾切除术. 世界华人消化杂志 2010; 18(33): 3533-3538 [DOI: 10.11569/wcjd.v18.i33.3533] [Reference Citation Analysis]
28 Kakinoki K, Okano K, Suto H, Oshima M, Hagiike M, Usuki H, Deguchi A, Masaki T, Suzuki Y. Hand-assisted laparoscopic splenectomy for thrombocytopenia in patients with cirrhosis. Surg Today. 2013;43:883-888. [PMID: 23143171 DOI: 10.1007/s00595-012-0413-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
29 Shi XB, Feng JK, Wang JH, Jiang XQ. Does splenectomy significantly improve the prognosis of hepatocellular carcinoma patients with hypersplenism? A systematic review and meta-analysis. Ann Transl Med 2021;9:641. [PMID: 33987339 DOI: 10.21037/atm-20-6748] [Reference Citation Analysis]
30 Yoshizumi T, Mori M. Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy. Surg Today 2020;50:21-9. [PMID: 31555908 DOI: 10.1007/s00595-019-01881-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
31 Gong C, Qin X, Yang J, Guo T. The Best Anticoagulation Strategy for Cirrhotic Patients who Underwent Splenectomy: A Network Meta-Analysis. Gastroenterol Res Pract 2017;2017:9216172. [PMID: 28676822 DOI: 10.1155/2017/9216172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Le A, Zhang L, Liu W, Li X, Ren J, Ning A. A case control study on the structural equation model of the mechanism of coagulation and fibrinolysis imbalance in chronic schistosomiasis. Medicine (Baltimore) 2017;96:e6116. [PMID: 28207534 DOI: 10.1097/MD.0000000000006116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
33 Han JB, Shu QH, Zhang YF, Yi YX. Predictive Value of Inflammation Biomarkers in Patients with Portal Vein Thrombosis. J Clin Transl Hepatol 2021;9:384-91. [PMID: 34221924 DOI: 10.14218/JCTH.2020.00159] [Reference Citation Analysis]